Podcast
MSL Talk: Tom Caravela
COMP: How HR Determines Compensation and Titles for Job Offers
Summary
In this episode, Chris Castin joins Tom Caravela to delve into the intricacies of compensation and negotiation processes for MSL roles. They explore how to prepare for job offer negotiations while emphasizing the importance of transparency and the risks of over-negotiating. Chris provides insights into HR perspectives and how offers are determined using formulas and data, highlighting the significance of internal equity. The discussion covers the role of job titles, leveling, and the impact of experience on role effectiveness. They also analyze written job offers, discuss sign-on bonuses, and offer advice on responding to offers with effective negotiation strategies. The episode concludes with practical advice for MSLs navigating job offers.
My guest today is Chris Castin, Senior Director, Talent Acquisition NKARTA Therapeutics and we discuss how HR departments determine compensation and titles for job offers
Chris shares…
👉 The HR formula for determining job offers
👉 What you need to know to negotiate an offer
👉 What information is expected in advance of the job offer
👉 How and why sign-on bonuses are used
👉 The way HR determines titles and leveling
MSL job negotiation, HR compensation strategies, job offer negotiation tips, internal equity in job offers, sign-on bonuses in employment
Related Topics
You May Also Like
MSL Talk: Tom Caravela
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO